Elevance Health, Inc.
ELV
$428.79
$1.920.45%
NYSE
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 14.70% | 3.10% | 4.50% | -2.92% | -0.26% |
| Total Other Revenue | 15.55% | 24.21% | 9.69% | 15.82% | 8.43% |
| Total Revenue | 14.83% | 6.55% | 5.36% | -0.06% | 0.96% |
| Cost of Revenue | 15.60% | 6.91% | 7.66% | -3.27% | -0.78% |
| Gross Profit | 12.87% | 5.56% | -0.38% | 8.34% | 5.66% |
| SG&A Expenses | 18.05% | 23.96% | -0.24% | 8.10% | 5.19% |
| Depreciation & Amortization | 33.62% | -17.05% | -42.45% | -26.70% | -50.64% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 16.20% | 10.47% | 5.45% | -0.85% | 0.18% |
| Operating Income | -1.97% | -58.94% | 3.50% | 11.99% | 11.64% |
| Income Before Tax | -4.83% | -39.46% | -16.99% | 22.33% | 12.22% |
| Income Tax Expenses | -11.16% | 13.53% | 3.11% | 17.09% | 12.20% |
| Earnings from Continuing Operations | -2.89% | -50.30% | -22.46% | 23.98% | 12.23% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 66.67% | -80.00% | 172.73% | 66.67% | 80.00% |
| Net Income | -2.80% | -51.17% | -21.18% | 24.12% | 12.92% |
| EBIT | -1.97% | -58.94% | 3.50% | 11.99% | 11.64% |
| EBITDA | -0.59% | -51.03% | -1.28% | 7.21% | 6.09% |
| EPS Basic | -0.10% | -50.18% | -20.02% | 26.56% | 15.25% |
| Normalized Basic EPS | -2.08% | -69.41% | 4.96% | 14.87% | 15.41% |
| EPS Diluted | 0.21% | -50.17% | -20.00% | 26.44% | 15.54% |
| Normalized Diluted EPS | -1.80% | -69.41% | 4.96% | 14.77% | 15.73% |
| Average Basic Shares Outstanding | -2.71% | -1.99% | -1.44% | -1.93% | -2.02% |
| Average Diluted Shares Outstanding | -2.99% | -1.99% | -1.44% | -1.85% | -2.29% |
| Dividend Per Share | 4.91% | 10.14% | 10.14% | 10.14% | 10.14% |
| Payout Ratio | 0.05% | 1.21% | 0.38% | -0.13% | -0.04% |